just pulled this off vla website....if this timeline works as per their intentions, and considering other trials will be underway, then there is a possibility we could become a target for a takeover in as little as 6 months ..IMO....Obviously depends on results etc etc
Here is the info off website
=========================================
"Phase II Melanoma Trial
Viralytics has lodged an Investigational New Drug (IND) application with the Food and Drug Administration (FDA), which will allow the Company to carry out its Phase II melanoma trial in the USA. Viralytics is planning to run this trial in other countries as well as the USA.
The IND application is currently under review by the FDA.
The proposed Phase II study is entitled the CALM Study (CAVATAK? in Late stage Melanoma). This will be a 63 patient trial. The dosing schedule provides for injections of CAVATAK? into multiple tumours over an 18 week treatment phase and monitoring for progression free survival at 6 months. Patients and clinicians seeking further information on this trial can visit our Clinical Trial page.
VLA Price at posting:
91.0¢ Sentiment: Buy Disclosure: Held
